Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. (Q53358580)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. |
scientific article |
Statements
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. (English)
Jeffrey L Seeburger
Daniel J Holder
Marc Combrinck
Catharine Joachim
Omar Laterza
Michael Tanen
Aimee Dallob
Derek Chappell
Karen Snyder
Mary Flynn
Adam Simon
Vijay Modur
William Z Potter
Gordon Wilcock
Mary J Savage
A David Smith
1 January 2015
44
2
525-539